Trending: Oil | Gold | BITCOIN | EUR/USD | GBP/USD

Pfizer regains footing - Analysis - 18-01-2018

Economies.com
2018-01-18 12:59 UTC

Pfizer's stock (PFE) jumped higher in the intraday levels, scoring a fresh profit of 1.58% in the last session, or 0.58 points, and attacking the pivotal resistance of 37.39, amid positive pressure from the 50-day SMA, with positive signals from the RSI, while the stock trades within an ascending price channel that guided recent short-term trading. 

 

Therefore we expect more gains for the stock, especially if the resistance of 37.39 was breached, targeting the next one at 38.21. 

Was this useful?

Thanks for your feedback.

McDonald's attacks current resistance - Analysis - 18-01-2018

Economies.com
2018-01-18 12:57 UTC

McDonald's stock (MCD) rose in the intraday levels, scoring a profit of 0.75% in the last session, or 1.30 points, and attacking the resistance of 175.55, amid positive support from the 50-day SMA, with positive signals from the RSI, coupled with the dominance of the main upward trend in the medium and short terms.

More

Morgan Stanley boosted by current support - Analysis - 18-01-2018

Economies.com
2018-01-18 12:55 UTC

Morgan Stanley's stock (MS) returned higher in the intraday levels, scoring a profit of 1.37% in the last session, or 0.75 points, after leaning on the support of 53.86, lending it positive momentum and sending it higher anew, amid positive pressure from the 50-day SMA, while trading within an ascending price channel in the short term.

More

Ford pierces negative pattern's support - Analysis - 18-01-2018

Economies.com
2018-01-18 12:54 UTC

Ford Motor Company's stock (F) skidded in the intraday levels, recording a new loss of 7.02% in the last session, or 0.92 points, and breaching the support of the Rising Wedge pattern that formed in the short term as shown in the attached chart, with a noticeable rise in trading volumes, exposing the stock to negative pressure and nudging it past the 50-day SMA support, with negative signals from the RSI.

More